相关实验视频
Updated: Jan 14, 2026

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.8K
肺形癌与介质细胞-上皮细胞转变因子 (MET) 突变:一个侵略性的实体
Yuta Takemura1, Kazuki Fukumoto1, Akinori Sasaki2
1Internal Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, JPN.
Cureus
|October 22, 2025
概括
肺形癌 (PPC),一种罕见的非小细胞肺癌 (NSCLC),存在诊断方面的挑战. 早期全面的基因组分析,包括MET外显子14跳转突变,对于在侵袭性病例中及时针对性治疗规划至关重要.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 肺部医学 肺部医学
背景情况:
- 肺形癌 (PPC) 是一种侵袭性,罕见的非小细胞肺癌 (NSCLC) 亚型.
- 由于生物检查材料有限,PPC的特点是快速进展和诊断困难.
- 这些诊断挑战往往导致开始适当治疗的延迟.
研究的目的:
- 突出诊断的挑战,在疑似NSCLC的病例与快速的临床恶化.
- 强调综合基因组分析在识别可操作突变中的作用.
- 强调及时进行分子检测对于罕见肺癌治疗规划的重要性.
主要方法:
- 一个临床病例的介绍,一个年长的女性患者怀疑NSCLC和快速下降.
- 细针活检 (FNB) 给出了不确定的组织学亚型.
- 综合基因组面板分析以确定特定突变,包括MET外基因14跳转.
主要成果:
- 基因组测试发现了一个介质细胞-上皮细胞转变因子 (MET) 异构体14跳转突变.
- 计划使用MET抑制剂治疗,但不能在患者死亡之前进行.
- 尸体解剖证实了肺形癌 (PPC) 的诊断.
结论:
- 早期的综合性基因组分析对于怀疑的NSCLC病例具有不确定的组织学至关重要.
- 识别可操作的突变,如MET外因子14跳转,可以促进分子向治疗.
- 及时的治疗计划对于改善PPC等快速进展的恶性瘤的结果至关重要.
相关概念视频
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K

